HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Studies on relationship between histology, tumor markers (prostatic acid phosphatase.prostate specific antigen.gamma-seminoprotein.leu-7) and clinical course in prostate cancer].

Abstract
We are interested in the therapeutic response to chemotherapy and radiotherapy of relapsed prostate cancer. In 9 cases of prostate cancer treated by endocrine therapy, tumor markers (PAP.PA.gamma-Sm.Leu-7) and cell types at the start of endocrine therapy and that taken at a hormone independent point were compared between prostatic tissue obtained. All cases had a period of response to endocrine therapy, but subsequently relapsed. The results were divided into the following 3 groups: Group I (changed cell type.decreased positive rate of markers) had the shortest response duration to endocrine therapy and there was no response to chemotherapy; Group II (unchanged cell type.decreased positive rate of markers) had a long response duration and slow progression under endocrine therapy; Group III (unchanged cell type.unchanged positive rate of markers) was chemo- or radiotherapy sensitive during post-endocrine therapy relapse. These results suggest that this is an effective method which dictated the choice of treatment method and allowed an approximate prognosis for relapsed prostate cancer previously treated by endocrine therapy.
AuthorsT Tanahashi, K Namba, T Murao
JournalNihon Hinyokika Gakkai zasshi. The japanese journal of urology (Nihon Hinyokika Gakkai Zasshi) Vol. 81 Issue 5 Pg. 680-5 (May 1990) ISSN: 0021-5287 [Print] Japan
PMID1695956 (Publication Type: Journal Article)
Chemical References
  • Antigens, Differentiation
  • Biomarkers, Tumor
  • CD57 Antigens
  • Prostatic Secretory Proteins
  • Proteins
  • Seminal Plasma Proteins
  • beta-microseminoprotein
  • Gonadotropin-Releasing Hormone
  • Diethylstilbestrol
  • Acid Phosphatase
Topics
  • Acid Phosphatase (analysis)
  • Aged
  • Aged, 80 and over
  • Antigens, Differentiation (analysis)
  • Biomarkers, Tumor (analysis)
  • CD57 Antigens
  • Combined Modality Therapy
  • Diethylstilbestrol (therapeutic use)
  • Gonadotropin-Releasing Hormone (therapeutic use)
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Orchiectomy
  • Prostatic Neoplasms (diagnosis, pathology, therapy)
  • Prostatic Secretory Proteins
  • Proteins (analysis)
  • Recurrence
  • Seminal Plasma Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: